In this episode, we unpack how Pasture Holdings Ltd navigated turbulent supply chain disruptions to mount a strategic comeback in the second half of FY2026. We explore how new routes unlocked recovery and what is next for the healthcare Group.

• Discover how alternative shipping lines bypass global tariff barriers

• Learn about the company expansion into wellness programmes in Malaysia

• Hear about the long-term transition from wholesale distribution to proprietary product ownership

WATCH THE EXPLAINER VIDEO BELOW:

LISTEN TO THE PODCAST BELOW:

BREAKING: 

In this episode, we delve into the financial world of Pasture Holdings Ltd, analysing their press release and results announcement for the six months ending 31 December 2024. Discover how Pasture achieved revenue growth of 25.2% due to increased pharmaceutical orders and shipments, particularly from Canada and Hong Kong.

We explore how this growth led to a 60.5% increase in gross profit, with gross margins expanding to 28% due to higher operational efficiencies. Join us as we dissect Pasture Holdings' strategic positioning in the Southeast Asian pharmaceutical market, and evaluate the potential risks and opportunities that lie ahead for this company, poised for growth and adaptability in an ever-evolving healthcare landscape.

There will be an AGM on

Event dates:

For more information, click here: PASTURE HOLDINGS LTD. 2023 AGM